The New York Times On The Web

 

 

|     UPDATED TUESDAY, MAY 3, 2005 12:27 PM ET |

The Inexplicable Survivors of a Widespread Epidemic
By Carol Pogash, NY Times Staff Writer
Peter DaSilva for The New York Times
Kai Brothers, left, who has H.I.V. but no signs of AIDS, with Dr. Jay Levy in his office.

SAN FRANCISCO, April 28 - Before powerful antiviral medicines became available, Kai Brothers lost his partner and many friends to AIDS. Thinking he was next, he quit his job, emptied his 401(k) and waited to die.

Nothing happened.

It has been 16 years since Mr. Brothers learned he was H.I.V. positive. Since then, he has never taken AIDS drugs or had any illnesses associated with the disease. Despite his good fortune, Mr. Brothers says he feels isolated.

"I don't identify with people who are H.I.V. negative because I'm not," he said. "I could infect someone. I don't identify with the positive people, because I don't have to deal with my health and medications and the things they have to worry about."

Once a month Mr. Brothers visits the laboratory of Dr. Jay Levy, a professor at the University of California, San Francisco, who is director of the university's laboratory for tumor and AIDS virus research. Since the epidemic began in 1981, Dr. Levy has been trying to understand why Mr. Brothers and others who are H.I.V. positive can remain medicine-free yet fit for decades, while the average person with H.I.V. progresses to AIDS within 10 years, if untreated.

An answer to that question could help in the development of a vaccine.

As a long-term survivor, also known as a long-term nonprogressor, Mr. Brothers, 42, is a much sought after anomaly. Dr. Levy believes that about 5 percent of people with H.I.V. are medicine-free and still healthy after 10 years.

Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases defines nonprogressors as treatment-free people with H.I.V. who have so little virus in their blood that it cannot be routinely detected. He suggests their numbers are far smaller, more like 0.2 to 0.4 percent.
- Continued -